$ESPR – IPO Boutique

IPO Boutique Research, Color & More Information for Subscribers

Secondaries Announced 8.8.17

Posted on August 8, 2017

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]

Secondaries announced 3.18.2015

Posted on March 18, 2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Esperion Therapeutics Symbol: ESPR Price: Last trade $99.60 Trade Date: 3/19 Shares: 1.5 million Underwriter(s) Credit Suisse, RBC Capital Markets, UBS[…]

error: Content is protected !!